Fmr LLC Cel Sci Corp Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Fmr LLC holds 2,985 shares of CVM stock, worth $2,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,985

Holding current value

$2,596

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.11 - $1.85 $3,313 - $5,522	2,985 New	2,985 $3,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $3.07 $323 - $927	302 New	302 $0
Q2 2023 Aug 11, 2023	SELL	$2.11 - $2.83 $7,779 - $10,434	-3,687 Reduced 84.76%	663 $1,000
Q1 2023 May 11, 2023	BUY	$2.17 - $3.13 $7,985 - $11,518	3,680 Added 549.25%	4,350 $10,000
Q4 2022 Feb 13, 2023	SELL	$1.99 - $3.52 $12,562 - $22,221	-6,313 Reduced 90.41%	670 $1,000
Q3 2022 Nov 10, 2022	SELL	$3.09 - $5.23 $7,422 - $12,562	-2,402 Reduced 25.59%	6,983 $22,000
Q2 2022 Aug 12, 2022	BUY	$2.58 - $4.99 $22,128 - $42,799	8,577 Added 1061.51%	9,385 $42,000
Q1 2022 May 13, 2022	BUY	$3.93 - $7.7 $3,175 - $6,221	808 New	808 $3,000

Others Institutions Holding CVM

# of Institutions

Shares Held

6.21M

Call Options Held

16.6K

Put Options Held

148K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $37.7M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account